Search results for: “oncology”
-
AstraZeneca and Daiichi Sankyo enter collaboration to develop and commercialise oncology treatment
•
LONDON: AstraZeneca has entered into a new global development and commercialisation agreement with Daiichi Sankyo Company Limited for…
-
The US Oncology Network finds cancer drug may benefit advanced COVID-19 patients
•
HOUSTON: Rapid improvements have been seen in acutely ill patients with COVID-19 treated with the cancer drug acalabrutinib…
-
Abcam acquires gene editing platform and oncology product portfolio of Applied StemCell
•
LONDON: Abcam Plc has announced the asset purchase of the gene editing platform and oncology product portfolio of…
-
ArcticZymes Technologies nominates Dr. Frank Mathias as new Chairman of the Board
•
TROMSØ, NORWAY: ArcticZymes Technologies (OSE:AZT) announced the nomination of Dr. Frank Mathias as the new Chairman of the…
-
Avacta Group appoints Shaun Chilton as non-executive chairman
•
LONDON: Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics,…
-
Syncona Ltd adds iOnctura and Yellowstone Biosciences to it’s portfolio
•
LONDON: Syncona Ltd has added two new companies to its portfolio, iOnctura and Yellowstone Biosciences. Syncona has invested…
-
AstraZeneca to deliver $80 billion revenue by 2030
•
LONDON: AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8…
-
BioPharma Credit signs $400 million financing deal with Novocure
•
LONDON: BioPharma Credit PLC, a leading debt investment trust listed on the London Stock Exchange (LSE: BPCR), has…
-
Iktos appoints Roman Fleck as Chairman of the Board
•
PARIS: Iktos, a company specialized in Artificial Intelligence for new drug design, announced the appointment of Roman Fleck…
-
AstraZeneca reports 19% increase in Q1 2024 revenue to $12.67 billion
•
LONDON: AstraZeneca has kicked off the year with a remarkable 19% increase in Total Revenue, reaching $12.679 billion…
-
Angle plc signs new commercial agreement with AstraZeneca
•
LONDON: ANGLE plc (AIM:AGL), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use…
-
Outrun Therapeutics launches with a $10m seed financing
•
Outrun Therapeutics, a pioneering force in E3 ligase inhibition and protein stabilization, has announced its emergence from stealth…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.